CSMYF (COSMOS Pharmaceutical) Cyclically Adjusted PS Ratio: (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSMYF COSMOS Pharmaceutical Corp CSMYF
93 GF Score
Price $37.06
GF Value $50.48
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is COSMOS Pharmaceutical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


COSMOS Pharmaceutical  (OTCPK:CSMYF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Related Terms


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Chart

COSMOS Pharmaceutical Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.85 0.72 0.90 0.00

COSMOS Pharmaceutical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.89 0.73 0.00 0.00

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Cyclically Adjusted PS Ratio falls into.


CSMYF
93GF Score
COSMOS Pharmaceutical Corp CSMYF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

COSMOS Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

COSMOS Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2026 is calculated as:

For example, COSMOS Pharmaceutical's adjusted Revenue per Share data for the three months ended in Feb. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=22.225/112.2000*112.2000
=22.225

Current CPI (Feb. 2026) = 112.2000.

COSMOS Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201605 13.859 98.200 15.835
201608 15.787 97.900 18.093
201611 14.026 98.600 15.961
201702 13.813 98.100 15.798
201705 14.868 98.600 16.919
201708 15.949 98.500 18.167
201711 14.785 99.100 16.739
201802 16.365 99.500 18.454
201805 16.948 99.300 19.150
201808 17.466 99.800 19.636
201811 16.136 100.000 18.105
201902 17.391 99.700 19.571
201905 18.445 100.000 20.695
201908 19.560 100.000 21.946
201911 18.648 100.500 20.819
202002 19.234 100.300 21.516
202005 22.559 100.100 25.286
202008 22.530 100.100 25.253
202011 21.166 99.500 23.868
202102 21.271 99.800 23.914
202105 21.377 99.400 24.130
202108 21.771 99.700 24.501
202111 20.134 100.100 22.568
202202 20.565 100.700 22.914
202205 19.259 101.800 21.227
202208 19.240 102.700 21.020
202211 17.540 103.900 18.941
202302 19.198 104.000 20.712
202305 20.397 105.100 21.775
202308 21.075 105.900 22.329
202311 19.790 106.900 20.771
202402 20.145 106.900 21.144
202405 20.211 108.100 20.978
202408 22.587 109.100 23.229
202411 20.036 110.000 20.437
202502 20.506 110.800 20.765
202505 22.567 111.800 22.648
202508 23.305 112.100 23.326
202511 21.534 113.200 21.344
202602 22.225 112.200 22.225

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?

Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued. The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48. GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.

Key valuation signals for CSMYF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


COSMOS Pharmaceutical Business Description

Other Exchanges 3349:Japan
Address 10-1 Hakataeki Higashi 2-chome, 4th floor, JR Hakata Station East NS Building S, Hakata-ku, Fukuoka Prefecture, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score

Get the complete analysis for CSMYF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.06
Price
$50.48
GF Value